DexCom Non-GAAP EPS of $0.17 misses by $0.02, revenue of $696.2M misses by $13.13M
DexCom press release  (NASDAQ:DXCM): Q2  Non-GAAP EPS of $0.17  misses by $0.02.
Revenue of $696.2M (+17.0% Y/Y)  misses by $13.13M.
Shares -7%.
Non-GAAP Gross Profit Margin of approximately 65%
Non-GAAP Operating Margin of approximately 16%

FY 2022 Guidance:Â Revenue expected between approximately $2.86 - 2.91 billion (17-19% growth), vs. consensus of $2.93 billion

Non-GAAP Gross Profit Margin of approximately 65%
Non-GAAP Operating Margin of approximately 16%
Adjusted EBITDA Margin of approximately 25%